EGFR CART Cells for Patients With Metastatic Colorectal Cancer

ABSTRACT: This is a clinical study to observe the maximum tolerated dose (MTD) and the safety and feasibility of chimeric antigen receptor EGFR (EGFR CART) cells in metastatic patients with colorectal cancer.

DISEASE(S): Egfr-positive Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2244323 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR